Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Supercharge Your Portfolio With 2 Small-Cap Investments

Page 1 of 2

If you were to cross a Bugatti Veyron with a McLaren F1 — two cars capable of reaching 60 mph in less than 3.2 seconds — you’d get a super machine able to leap tall buildings in a single bound.

You get the same power when you take two high-flying sectors of the market and combine them into a single exchange-traded fund (ETF). That is the true beauty behind ETFs: the ability to invest in very precise niches of the market that, when multiplied, result in head-turning returns.

Today, let’s look at a combination of small caps with health care and technology.

Small-caps stocks have been on a tear and are poised to continue their streak for some time longer. The iShares S&P SmallCap 600 Index (ETF) (NYSEARCA:IJR) hit an all-time high Oct. 29 and is up about 28% year to date. In fact, this index of core small caps is up 36% over the past 12 months, 50% over the past two years and 130% over the past five, outpacing the Dow Jones Industrial Average on all fronts.

As Bloomberg reports, in three out of the past four periods in which small-caps trounced the Dow so dramatically, equities kept moving higher and the U.S. economy strengthened the following year.

Investing in individual small-cap stocks can be tricky, though. They’re capable of running up the hill very quickly but going downhill twice as fast — with a steeper drop.

PowerShares QQQ Trust, Series 1 (ETF) (QQQ)

That’s why I love these two ETFs: PowerShares S&P SmallCap Hlth Cr Ptflo (NASDAQ:PSCH) and PowerShares S&P SmlCp Inftn Thgy Pfo (NASDAQ:PSCT). Up 38% and 33% year to date, respectively, these two top-performing ETFs offer safer ways to capitalize.

Let’s take a look at each ETF.

PowerShares S&P SmallCap Hlth Cr Ptflo

This ETF benefits directly from the trends of the “Graying of America,” higher medical costs, the Affordable Care Act (aka Obamacare), etc. The 65 companies that make up the ETF obviously do business in health care products and services, but that includes a nice mix of pharmaceuticals, medical technology and supplies, and biotechnology.

While 72.9% of the fund is composed of small-cap growth companies and another 16.5% is small-cap value stocks, it includes a 10.6% stake in mid-cap growth as well. Its top holdings include:

Centene Corp (NYSE:CNC), a company involved in Medicare and Medicaid programs and services. Its revenue from services for the third quarter totaled $2.7 billion, a 24% increase from the same period last year. CNC is up 35% year to date.

Align Technology, Inc. (NASDAQ:ALGN), maker of invisible dental braces, reported a 62% increase in third-quarter revenue over 2012. ALGN is up nearly 100% in 2013.

Questcor Pharmaceuticals Inc (NASDAQ:QCOR), maker of drugs for the treatment of multiple sclerosis, has been popular as of late, with an average 1.1 million shares trading over 30 days. No surprise why: QCOR is up 109% year to date.

With average trading volume around 28,000 shares a day and $156 million in assets, PSCH is a thinly traded ETF with plenty of potential.

PowerShares S&P SmlCp Inftn Thgy Pfo

Small caps and information technology (IT) stocks are a match made in heaven. IT is perhaps the largest growing market domestically and internationally with plenty of smaller companies positioned to take their share of it.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!